Comparing Lucentis vs Vabysmo
| Lucentis (ranibizumab) | Vabysmo (faricimab) |
|
|---|
| Lucentis (ranibizumab) | Vabysmo (faricimab) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Macular Edema Following Retinal Vein Occlusion, Macular Degeneration, Myopic Choroidal Neovascularization, Macular Edema, Diabetic Macular Edema, Diabetic Retinopathy. Lucentis may... View more |
Prescription only
Prescribed for Macular Degeneration, Diabetic Macular Edema, Macular Edema, Macular Edema Following Retinal Vein Occlusion. Vabysmo may also be used for purposes not listed in this medication guide. |
Related suggestions Macular Degeneration
Diabetic Macular Edema
Macular Edema
Macular Edema Following Retinal Vein Occlusion
Popular comparisons
|
|||||||||||||||
| More about Lucentis (ranibizumab) | More about Vabysmo (faricimab) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Lucentis has an average rating of 6.1 out of 10 from a total of 15 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 27% reported a negative effect. |
Vabysmo has an average rating of 7.8 out of 10 from a total of 31 ratings on Drugs.com. 58% of reviewers reported a positive effect, while 6% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Lucentis side effects |
View all Vabysmo side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Lucentis prices |
View all Vabysmo prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other ranibizumab brands include: Byooviz, Cimerli, Susvimo |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
216 hours |
180 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 1 drugs are known to interact with Lucentis:
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
N/A |
January 28, 2022 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.